Affiliated Hospital of Nanjing University of TCM
Nanjing, Jiangsu, 210029, China
NCT Number: NCT03616444
This study evaluates Shenbai Granules in Prevention of Colorectal Adenomatous Polyp Recurrence After Colonoscopy.Half of participants will receive Shenbai Granules,while the other half will receive a placebo.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 2 / Phase 3
Nanjing, Jiangsu, 210029, China
There is no internationally recognized standard treatment for the prevention of recurrence of colorectal adenomatous polyps.
Based on TCM,previous studies have found that Shenbai Granules can significantly reduce the recurrence and deterioration rate of colorectal adenomatous polyps,reduce the proliferation of tumor cells and promote apoptosis of tumor cells.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the first year, the trial granules will be started after enrollment for 3 months; In the second year, the trial granules will be started in the first 3 months; Each participant should have completed 6 months of trial granules.
Other names: placebo
Time frame: 2 years
The ratio of the number of patients with new adenoma detected by colonoscopy to the total number of cases in this group during follow-up.
Time frame: 2 years
The ratio of the number of patients with any polypoid lesions detected by colonoscopy to the total number of cases in this group during follow-up.
Time frame: 2 years
The ratio of the number of patients with high-risk adenomas detected by colonoscopy to the total number of cases in this group during follow-up.
Time frame: 2 years
The ratio of the number of patients with sessile serrated lesions detected by colonoscopy to the total number of cases in this group during follow-up.
Jiangsu Famous Medical Technology Co., Ltd.
Industry
Clinical Evidence-based Evaluation of the Efficacy of Shenbai Granules in Preventing Recurrent Colorectal Adenomas After Polypectomy and Its Therapeutic Mechanism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05357430
Gastroenterology
Yangzhou, Jiangsu, China
View Trial DetailsNCT06515834
Gastroenterology
Sumida-Ku, Tokyo, Japan
View Trial DetailsNCT04692792
Body Weight, Gastroenterology
Taichung, Taiwan
View Trial DetailsNCT02979509
Gastroenterology, Lesions
Gainesville, Florida, United States
View Trial Details